Integra LifeSciences Holdings

NasdaqGS:IART Stock Report

Mkt Cap: US$3.6b

Integra LifeSciences Holdings Past Performance

How has Integra LifeSciences Holdings performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


26.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: IART has a large one-off loss of $58.1M impacting its June 30 2022 financial results.

Growing Profit Margin: IART's current net profit margins (10.6%) are lower than last year (13.6%).


Past Earnings Growth Analysis

Earnings Trend: IART's earnings have grown significantly by 26.9% per year over the past 5 years.

Accelerating Growth: IART's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: IART had negative earnings growth (-19.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (0.6%).


Return on Equity

High ROE: IART's Return on Equity (10%) is considered low.


Discover strong past performing companies